Sabrina Riedl

1.0k total citations
17 papers, 849 citations indexed

About

Sabrina Riedl is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Sabrina Riedl has authored 17 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Microbiology and 6 papers in Immunology. Recurrent topics in Sabrina Riedl's work include RNA Interference and Gene Delivery (12 papers), Antimicrobial Peptides and Activities (11 papers) and Lipid Membrane Structure and Behavior (8 papers). Sabrina Riedl is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Antimicrobial Peptides and Activities (11 papers) and Lipid Membrane Structure and Behavior (8 papers). Sabrina Riedl collaborates with scholars based in Austria, Australia and Germany. Sabrina Riedl's co-authors include Dagmar Zweytick, Karl Lohner, Beate Rinner, Helmut Schaider, Martin Asslaber, Sonja M. Walzer, Alexandra Novak, Regina Leber, Jae‐Yeon Choi and Dennis R. Voelker and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.

In The Last Decade

Sabrina Riedl

17 papers receiving 845 citations

Peers

Sabrina Riedl

MICRO

IMMUN

ONCOL

Andreja Majerle Slovenia

Barbara Lelli Italy

Satoe Kobayashi Japan

Vítor Teixeira Portugal

William F. Walkenhorst United States

Ernesto E. Ambroggio Argentina

Nagasundarapandian Soundrarajan South Korea

Ting‐Yi Wang United States

Anne C. Conibear Australia

Rida Mourtada United States

Andreja Majerle Slovenia

Sabrina Riedl

504 ×0.8

230 ×0.5

MICRO

152 ×0.8

IMMUN

82 ×1.1

57 ×0.9

ONCOL

Citations per year, relative to Sabrina Riedl Sabrina Riedl (= 1×) peers Andreja Majerle

Countries citing papers authored by Sabrina Riedl

Since Specialization

Citations

This map shows the geographic impact of Sabrina Riedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrina Riedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrina Riedl more than expected).

Fields of papers citing papers by Sabrina Riedl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabrina Riedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrina Riedl. The network helps show where Sabrina Riedl may publish in the future.

Co-authorship network of co-authors of Sabrina Riedl

This figure shows the co-authorship network connecting the top 25 collaborators of Sabrina Riedl. A scholar is included among the top collaborators of Sabrina Riedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabrina Riedl. Sabrina Riedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Riedl, Sabrina, Vajinder Kumar, Robert Kourist, et al.. (2023). Lectin‐anticancer peptide fusion demonstrates a significant cancer‐cell‐selective cytotoxic effect and inspires the production of “clickable” anticancer peptide in Escherichia coli. Protein Science. 32(12). e4830–e4830. 3 indexed citations

Devenish, Sean R. A., Sebastian Fiedler, Sabrina Riedl, et al.. (2022). FULL-MDS: Fluorescent Universal Lipid Labeling for Microfluidic Diffusional Sizing. Analytical Chemistry. 95(2). 587–593. 6 indexed citations

Groeber‐Becker, Florian, et al.. (2022). In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis. Biomedicines. 10(11). 2961–2961. 1 indexed citations

Richtig, Erika, Birgit Hirschmugl, Mariangela Garofalo, et al.. (2021). MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy. International Journal of Molecular Sciences. 22(21). 11318–11318. 1 indexed citations

Tetyczka, Carolin, Claudia Meindl, Eleonore Fröhlich, et al.. (2021). Cytokine-Mediated Inflammation in the Oral Cavity and Its Effect on Lipid Nanocarriers. Nanomaterials. 11(5). 1330–1330. 11 indexed citations

Riedl, Sabrina, et al.. (2021). Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma. International Journal of Molecular Sciences. 22(16). 8469–8469. 18 indexed citations

Riedl, Sabrina, et al.. (2020). Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1862(8). 183264–183264. 9 indexed citations

Heitzer, Ellen, Arwin Groenewoud, Birgit Lohberger, et al.. (2019). Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization. Scientific Reports. 9(1). 4096–4096. 7 indexed citations

Riedl, Sabrina, Beate Rinner, Regina Leber, et al.. (2019). Interaction of two antitumor peptides with membrane lipids – Influence of phosphatidylserine and cholesterol on specificity for melanoma cells. PLoS ONE. 14(1). e0211187–e0211187. 50 indexed citations

10.

Riedl, Sabrina, Beate Rinner, Helmut Schaider, et al.. (2017). In vitroandin vivocytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma. Oncotarget. 8(42). 71817–71832. 14 indexed citations

11.

Riedl, Sabrina, Regina Leber, Beate Rinner, et al.. (2015). Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(11). 2918–2931. 46 indexed citations

12.

Riedl, Sabrina, Beate Rinner, Helmut Schaider, Karl Lohner, & Dagmar Zweytick. (2014). Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine. BioMetals. 27(5). 981–997. 36 indexed citations

13.

Riedl, Sabrina, Beate Rinner, Gerald N. Rechberger, et al.. (2014). Interaction of an Antitumor Peptide with Lipids of the Cancer Plasma Membrane - Formation of Membrane Domains and Influence of Cholesterol. Biophysical Journal. 106(2). 88a–88a. 1 indexed citations

14.

Zweytick, Dagmar, Boštjan Japelj, Eugenia Mileykovskaya, et al.. (2014). N-acylated Peptides Derived from Human Lactoferricin Perturb Organization of Cardiolipin and Phosphatidylethanolamine in Cell Membranes and Induce Defects in Escherichia coli Cell Division. PLoS ONE. 9(3). e90228–e90228. 34 indexed citations

15.

Riedl, Sabrina, et al.. (2011). Targeting the cancer cell membrane specifically with human lactoferricin derivatives. Annals of Oncology. 22. 33–33. 7 indexed citations

16.

Riedl, Sabrina, Dagmar Zweytick, & Karl Lohner. (2011). Membrane-active host defense peptides – Challenges and perspectives for the development of novel anticancer drugs. Chemistry and Physics of Lipids. 164(8). 766–781. 337 indexed citations

17.

Riedl, Sabrina, Beate Rinner, Martin Asslaber, et al.. (2011). In search of a novel target — Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1808(11). 2638–2645. 268 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact